EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitLeitlinieOpen Access · CC BY 4.0

The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology

Sandro Feriozzi, Yuri Battaglia, Calogero Lino Cirami, Concetta Gangemi, Gaetano La Manna, Loreto Gesualdo, Maria Lorenza Muiesan, Antonello Pani, Federico Pieruzzi, Flavio Ribichini, Stefano Taddei, Stefano Bianchi

Journal of Nephrology · 08.09.2025 · 38 (8) · 2053-2065

DOI: 10.1007/s40620-025-02406-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Nephrology, online erschienen am 08.09.2025. Verfasst von Sandro Feriozzi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Nephrology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. sandro.feriozzi@policlinicocampus.it. Hauptthemen laut MEDLINE: Hypertension, Renal Insufficiency, Chronic, Sympathectomy, Kidney. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: World Health Organization.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Hypertension is a clinical condition associated with an increase in cardiovascular morbidity and mortality. In chronic kidney disease (CKD), hypertension is also a driver of faster disease progression. Correct and appropriate treatment with antihypertensive medication reduces the risk of cardiovascular events and slows kidney disease progression. However, not all hypertensive patients achieve the desired blood pressure goals despite multiple antihypertensive therapies, and these are defined as patients with uncontrolled or resistant hypertension. Renal denervation has been successfully proposed to mitigate the hyperactivity of the sympathetic nervous system in patients with uncontrolled/resistant hypertension. The guidelines of the European Society of Cardiology and the European Society of Hypertension include renal denervation as a therapeutic option for treating hypertension in patients with uncontrolled or resistant hypertension. However, in patients with CKD, diffusion of the procedure has been limited by concerns over possible adverse effects on kidney function. Over the last few years, the improvement of the device-based procedure and the growing experience accumulated in several Nephrology centers have increased the use of renal denervation in patients with CKD. In patients with uncontrolled/resistant hypertension with a significant reduction of glomerular filtration rate (< 40 ml/min/1.73 m 2 ), on dialysis, or living with a kidney transplant, the procedure significantly reduces blood pressure values over time without negative effects on kidney function. Taking into account the effectiveness of renal denervation in patients with uncontrolled or resistant hypertension and CKD, and the lack of defined indications concerning renal denervation in CKD, the Italian Society of Nephrology has decided to publish a position paper reviewing the available evidence in the medical literature. Graphical abstract

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypertensionRenal Insufficiency, ChronicSympathectomyKidneyBlood PressureHumansTreatment OutcomeAntihypertensive AgentsDrug ResistanceNephrology

Stichwörter der Autor:innen

Chronic kidney diseaseDialysisKidney transplantRenal denervationUncontrolled and resistant hypertension

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Nephrology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy. sandro.feriozzi@policlinicocampus.it.
  • Department of Medicine, University of Verona, Verona, Italy.
  • Nephrology and Dialysis Unit, Pederzoli Hospital, Peschiera del Garda, Verona, Italy.
  • Nephrology, Dialysis and Transplantation Unit, Careggi University Hospital, Florence, Italy.
  • Division of Nephrology and Dialysis, University Hospital of Verona, Verona, Italy.
  • Nephrology, Dialysis, and Kidney Transplant Unit, IRCCS-Azienda Ospedaliera, Universitaria di Bologna, Bologna, Italy.

Förderung

  • World Health Organization

Zitieren

APA

Feriozzi, S., Battaglia, Y., Cirami, C. L., Gangemi, C., La Manna, G., Gesualdo, L., Muiesan, M. L., Pani, A., Pieruzzi, F., Ribichini, F., Taddei, S., & Bianchi, S. (2025). The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology. Journal of Nephrology, 38(8), 2053-2065. https://doi.org/10.1007/s40620-025-02406-2

Vancouver

Feriozzi S, Battaglia Y, Cirami CL, Gangemi C, La Manna G, Gesualdo L, et al. The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology. Journal of Nephrology. 2025;38(8):2053-2065. doi:10.1007/s40620-025-02406-2

BibTeX
@article{Feriozzi2025,
  author = {Feriozzi, Sandro and Battaglia, Yuri and Cirami, Calogero Lino and Gangemi, Concetta and La Manna, Gaetano and Gesualdo, Loreto and Muiesan, Maria Lorenza and Pani, Antonello and Pieruzzi, Federico and Ribichini, Flavio and Taddei, Stefano and Bianchi, Stefano},
  title = {The role of renal denervation for the treatment of hypertension in patients with chronic kidney disease: a position paper of the Italian Society of Nephrology},
  journal = {Journal of Nephrology},
  year = {2025},
  volume = {38},
  number = {8},
  pages = {2053--2065},
  doi = {10.1007/s40620-025-02406-2}
}
Kostenlos starten →